James D. Berry

13.0k total citations · 2 hit papers
161 papers, 5.0k citations indexed

About

James D. Berry is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, James D. Berry has authored 161 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Neurology, 68 papers in Genetics and 25 papers in Molecular Biology. Recurrent topics in James D. Berry's work include Amyotrophic Lateral Sclerosis Research (112 papers), Neurogenetic and Muscular Disorders Research (66 papers) and Dysphagia Assessment and Management (24 papers). James D. Berry is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (112 papers), Neurogenetic and Muscular Disorders Research (66 papers) and Dysphagia Assessment and Management (24 papers). James D. Berry collaborates with scholars based in United States, Canada and United Kingdom. James D. Berry's co-authors include Merit Cudkowicz, Jordan R. Green, Yana Yunusova, Robert H. Brown, Sabrina Paganoni, Robert Lawson, Karin L. Petersen, Nazem Atassi, Howard L. Weiner and J. R. Gillespie and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

James D. Berry

146 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons

2014 481 citations James D. Berry, Merit Cudkowicz et al. profile →
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD

2024 52 citations Katherine E. Irwin, Kerstin E. Braunstein et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James D. Berry United States	37	2.8k	1.6k	1.4k	910	722	161	5.0k
Lorne Zinman Canada	37	3.0k 1.1×	1.4k 0.9×	1.3k 0.9×	866 1.0×	437 0.6×	126	4.6k
Robert Sufit United States	32	4.1k 1.5×	2.4k 1.5×	1.7k 1.2×	946 1.0×	840 1.2×	93	6.9k
Zachary Simmons United States	44	4.5k 1.6×	1.9k 1.2×	1.5k 1.1×	830 0.9×	722 1.0×	185	7.2k
Andrea Calvo Italy	46	5.4k 1.9×	2.8k 1.8×	1.3k 0.9×	1.0k 1.1×	879 1.2×	195	7.1k
Dana Hilt United States	33	2.9k 1.0×	2.2k 1.4×	1.9k 1.4×	587 0.6×	364 0.5×	70	6.8k
Michael Benatar United States	47	6.0k 2.1×	1.9k 1.2×	1.3k 1.0×	835 0.9×	606 0.8×	175	7.8k
Nancy Stambler United States	24	2.8k 1.0×	1.5k 0.9×	442 0.3×	611 0.7×	237 0.3×	68	5.2k
Mark B. Bromberg United States	41	3.3k 1.1×	2.0k 1.2×	1.2k 0.9×	749 0.8×	235 0.3×	169	5.8k
Leonard H. van den Berg Netherlands	48	6.0k 2.1×	3.3k 2.0×	2.4k 1.8×	885 1.0×	925 1.3×	177	8.8k
Massimo Corbo Italy	38	2.2k 0.8×	781 0.5×	920 0.7×	617 0.7×	483 0.7×	199	4.2k

Countries citing papers authored by James D. Berry

Since Specialization

Citations

This map shows the geographic impact of James D. Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Berry more than expected).

Fields of papers citing papers by James D. Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Berry. The network helps show where James D. Berry may publish in the future.

Co-authorship network of co-authors of James D. Berry

This figure shows the co-authorship network connecting the top 25 collaborators of James D. Berry. A scholar is included among the top collaborators of James D. Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D. Berry. James D. Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calcagno, Narghes, Sarah Morgan, Neehar D. Parikh, et al.. (2025). Real‐World Clinical Experience With Sodium Phenylbutyrate and Taurursodiol at a Single Amyotrophic Lateral Sclerosis Center in the United States. European Journal of Neurology. 32(9). e70360–e70360.

Michaelis, T., Cecilia S. Lindestam Arlehamn, April Frazier, et al.. (2025). Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis. Nature. 647(8091). 970–978. 1 indexed citations

Lee, Ik Jae, Joanne Wuu, Elizabeth A. Harrington, et al.. (2024). Body mass index is lower in asymptomatic C9orf72 expansion carriers but not in SOD1 pathogenic variant carriers compared to gene negatives. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 25(7-8). 672–679.

Berry, James D., Sabrina Paganoni, Matthew Harms, et al.. (2024). Access for ALL in ALS: A large‐scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis. Muscle & Nerve. 70(6). 1140–1150. 1 indexed citations

Strączkiewicz, Marcin, Marta Karas, Stephen A. Johnson, et al.. (2024). Upper limb movements as digital biomarkers in people with ALS. EBioMedicine. 101. 105036–105036. 8 indexed citations

Irwin, Katherine E., Kerstin E. Braunstein, Irika R. Sinha, et al.. (2024). A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS–FTD. Nature Medicine. 30(2). 382–393. 52 indexed citations breakdown →

Connaghan, Kathryn P., Jordan R. Green, Stephen A. Johnson, et al.. (2024). The relationship of rate and pause features to the communicative participation of people living with ALS. Muscle & Nerve. 70(2). 217–225.

Genge, Angela, Leonard H. van den Berg, Glen Frick, et al.. (2023). Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis. JAMA Neurology. 80(10). 1089–1089. 11 indexed citations

Johnson, Stephen A., Marta Karas, Katherine M. Burke, et al.. (2023). Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures. npj Digital Medicine. 6(1). 34–34. 27 indexed citations

10.

Green, Jordan R., et al.. (2023). Acoustic Measures of Dysphonia in Amyotrophic Lateral Sclerosis. Journal of Speech Language and Hearing Research. 66(3). 872–887. 11 indexed citations

11.

Stipancic, Kaila L., et al.. (2022). Validity of Off-the-Shelf Automatic Speech Recognition for Assessing Speech Intelligibility and Speech Severity in Speakers With Amyotrophic Lateral Sclerosis. Journal of Speech Language and Hearing Research. 65(6). 2128–2143. 17 indexed citations

12.

Johnson, Stephen A., Ton Fang, Fabiola De Marchi, et al.. (2022). Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents. Drugs. 82(13). 1367–1388. 61 indexed citations

13.

Stipancic, Kaila L., et al.. (2021). “You Say Severe, I Say Mild”: Toward an Empirical Classification of Dysarthria Severity. Journal of Speech Language and Hearing Research. 64(12). 4718–4735. 36 indexed citations

14.

Marchi, Fabiola De, Ivana Munitić, Amedeo Amedei, et al.. (2021). Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact. Neuroscience & Biobehavioral Reviews. 127. 958–978. 34 indexed citations

15.

Quinn, Colin, Eric A. Macklin, Nazem Atassi, et al.. (2013). Post-lumbar puncture headache is reduced with use of atraumatic needles in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14(7-8). 632–634. 5 indexed citations

16.

Green, Jordan R., Yana Yunusova, Mili Kuruvilla-Dugdale, et al.. (2013). Bulbar and speech motor assessment in ALS: Challenges and future directions. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14(7-8). 494–500. 161 indexed citations

17.

Gillespie, J. R., et al.. (1979). Influence of Ruminal Insufflation on Pulmonary Function and Diaphragmatic Electromyography in Cattle. American Journal of Veterinary Research. 40(1). 26–31. 18 indexed citations

18.

Steffey, EP & James D. Berry. (1977). Flow Rates from an Intermittent Positive Pressure Breathing-Anesthetic Delivery Apparatus for Horses. American Journal of Veterinary Research. 38(5). 685–687. 7 indexed citations

19.

Steffey, Eugene P., J. R. Gillespie, James D. Berry, E. I. Eger, & E. A. Rhode. (1975). Circulatory Effects of Halothane and Halothane-Nitrous Oxide Anesthesia in the Dog: Spontaneous Ventilation. American Journal of Veterinary Research. 36(2). 197–200. 9 indexed citations

20.

Steffey, Eugene P., J. R. Gillespie, James D. Berry, E. I. Eger, & E. A. Rhode. (1974). Cardiovascular Effects of Halothane in the Stump-Tailed Macaque During Spontaneous and Controlled Ventilation. American Journal of Veterinary Research. 35(10). 1315–1319. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact